戻る Agenda
Session 2 Track 1: All Aboard the Globalization Train
Session Chair(s)
Taleen Kalebjian, PHARMD
Senior Manager, Medical Information , Gilead Sciences, Inc., United States
The trend towards medical information globalization is clear, but the path and final product can look different for each organization. The results from a survey of several biopharmaceutical companies show us why companies decide to globalize, how they approach this process, and key components to a successful shift towards a global medical information department. We will then see some of these key learnings in action as one company shares their globalization journey.
Learning Objective : - Describe current trends in medical information globalization in areas including infrastructure, aspects of department globalization, and the use of technology
- Compare various models of globalization
- Discuss the value of globalization in regards to the company, the department, and the patient
- Recognize key challenges associated with globalization and best practices for overcoming them
Speaker(s)
Mary Sendi, PHARMD
Medical Information & Review, Global US Regional Lead, Pfizer, United States
PhactMI Benchmark Study Results
Ghiesla Nel
Head of Global Medical Information, IPSEN PHARMA, France
MI Globalization – Partnering with Affiliates